Kenan
Kenan Onel, MD, PhD
Director, Roswell Park Center for Family Genetics and Cancer Prevention
Chair, Department of Clinical Genomics
Professor of Oncology
Kenan Onel, MD, PhD, is Professor of Oncology at Roswell Park Comprehensive Cancer Center in Buffalo New York, where he leads the Department of Clinical Genomics and serves as the founding Director of the Roswell Park Center for Family Genetics and Cancer Prevention. A physician-scientist and board-certified pediatric oncologist, Dr. Onel has devoted his career to caring for individuals and families at increased risk for hereditary cancer because of their genetics or family history.
Internationally recognized for his research, Dr. Onel studies the genetic contribution to cancer risk and response to therapy. He is a leader in the emerging field of functional genomics, integrating genetic discoveries with laboratory research to advance our understanding of cancer and improve patient care. His work has been supported by the National Institutes of Health and numerous foundations, and he has authored nearly 100 scientific publications, reviews, and book chapters.
Through both his clinical practice and research, Dr. Onel has dedicated his career to advancing cancer genetics, precision medicine, and the care of families affected by inherited cancer risk.
Kenan Onel, MD, PhD
- Director, Roswell Park Center for Family Genetics and Cancer Prevention
- Chair, Department of Clinical Genomics
- Professor of Oncology
Kenan Onel, MD, PhD, is Professor of Oncology at Roswell Park Comprehensive Cancer Center in Buffalo New York, where he leads the Department of Clinical Genomics and serves as the founding Director of the Roswell Park Center for Family Genetics and Cancer Prevention. A physician-scientist and board-certified pediatric oncologist, Dr. Onel has devoted his career to caring for individuals and families at increased risk for hereditary cancer because of their genetics or family history.
Internationally recognized for his research, Dr. Onel studies the genetic contribution to cancer risk and response to therapy. He is a leader in the emerging field of functional genomics, integrating genetic discoveries with laboratory research to advance our understanding of cancer and improve patient care. His work has been supported by the National Institutes of Health and numerous foundations, and he has authored nearly 100 scientific publications, reviews, and book chapters.
Through both his clinical practice and research, Dr. Onel has dedicated his career to advancing cancer genetics, precision medicine, and the care of families affected by inherited cancer risk.